Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagège AA.

Circulation. 2008 Mar 4;117(9):1189-200. doi: 10.1161/CIRCULATIONAHA.107.734103. Epub 2008 Feb 19.

2.

Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up.

Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat AP, Serruys PW.

J Am Coll Cardiol. 2003 Dec 17;42(12):2063-9.

3.

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.

Dib N, Michler RE, Pagani FD, Wright S, Kereiakes DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith BP, Korn R, Kreuger SK, Ghazoul M, MacLellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E.

Circulation. 2005 Sep 20;112(12):1748-55.

4.

Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy.

Eisen HJ.

Nat Clin Pract Cardiovasc Med. 2008 Sep;5(9):520-1. doi: 10.1038/ncpcardio1299. Epub 2008 Jul 22.

PMID:
18648335
5.

[Percutaneous transplantation of autologous myoblasts in ischemic cardiomyopathy].

Ince H, Petzsch M, Rehders TC, Kische S, Chatterjee T, Nienaber CA.

Herz. 2005 May;30(3):223-31. German.

PMID:
15902373
6.

Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure.

McConnell PI, del Rio CL, Jacoby DB, Pavlicova M, Kwiatkowski P, Zawadzka A, Dinsmore JH, Astra L, Wisel S, Michler RE.

J Thorac Cardiovasc Surg. 2005 Oct;130(4):1001. Epub 2005 Sep 2.

7.

Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease.

Brickwedel J, Gulbins H, Reichenspurner H.

Interact Cardiovasc Thorac Surg. 2014 Jan;18(1):61-6. doi: 10.1093/icvts/ivt434. Epub 2013 Oct 14.

8.

Skeletal myoblasts as a therapeutic agent.

Menasché P.

Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):7-17. Review.

PMID:
17631434
9.

Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N, Kurpisz M.

Am Heart J. 2004 Sep;148(3):531-7.

PMID:
15389244
10.

Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.

Veltman CE, Soliman OI, Geleijnse ML, Vletter WB, Smits PC, ten Cate FJ, Jordaens LJ, Balk AH, Serruys PW, Boersma E, van Domburg RT, van der Giessen WJ.

Eur Heart J. 2008 Jun;29(11):1386-96. doi: 10.1093/eurheartj/ehn171. Epub 2008 Apr 25.

PMID:
18441322
11.

Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction.

Herreros J, Prósper F, Perez A, Gavira JJ, Garcia-Velloso MJ, Barba J, Sánchez PL, Cañizo C, Rábago G, Martí-Climent JM, Hernández M, López-Holgado N, González-Santos JM, Martín-Luengo C, Alegria E.

Eur Heart J. 2003 Nov;24(22):2012-20.

PMID:
14613737
12.

A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.

Povsic TJ, O'Connor CM, Henry T, Taussig A, Kereiakes DJ, Fortuin FD, Niederman A, Schatz R, Spencer R 4th, Owens D, Banks M, Joseph D, Roberts R, Alexander JH, Sherman W.

Am Heart J. 2011 Oct;162(4):654-662.e1. doi: 10.1016/j.ahj.2011.07.020. Epub 2011 Sep 9.

PMID:
21982657
13.

Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation.

Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD.

J Am Coll Cardiol. 2003 Mar 5;41(5):879-88.

14.

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

Hudson MP, Armstrong PW, Ruzyllo W, Brum J, Cusmano L, Krzeski P, Lyon R, Quinones M, Theroux P, Sydlowski D, Kim HE, Garcia MJ, Jaber WA, Weaver WD.

J Am Coll Cardiol. 2006 Jul 4;48(1):15-20. Epub 2006 Jun 21.

15.

Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy.

Dib N, McCarthy P, Campbell A, Yeager M, Pagani FD, Wright S, MacLellan WR, Fonarow G, Eisen HJ, Michler RE, Binkley P, Buchele D, Korn R, Ghazoul M, Dinsmore J, Opie SR, Diethrich E.

Cell Transplant. 2005;14(1):11-9.

PMID:
15789658
16.

Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction.

Menasché P, Hagège AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D.

J Am Coll Cardiol. 2003 Apr 2;41(7):1078-83.

17.

Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs.

He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E, White D, Taylor DA, Wang J, Burkhoff D.

J Heart Lung Transplant. 2005 Nov;24(11):1940-9. Epub 2005 Aug 24.

PMID:
16297802
18.

Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial.

Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kałmucki P, Kurpisz M.

Eur Heart J. 2005 Jun;26(12):1188-95. Epub 2005 Mar 10.

PMID:
15764613
19.

Autologous myoblast transplantation for chronic ischemic mitral regurgitation.

Messas E, Bel A, Morichetti MC, Carrion C, Handschumacher MD, Peyrard S, Vilquin JT, Desnos M, Bruneval P, Carpentier A, Menasché P, Levine RA, Hagège AA.

J Am Coll Cardiol. 2006 May 16;47(10):2086-93. Epub 2006 Apr 24.

Supplemental Content

Support Center